Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Results
Phase 3
This trial was comparing fludarabine and cytarabine (FLA) with cytarabine, daunorubicin and etoposide (ADE) for relapsed or high risk acute myeloid leukaemia (AML).
Recruitment start: 1 January 2000
Recruitment end: 31 January 2004
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr DW Milligan
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer
Last reviewed: 7 January 2013
CRUK internal database number: 53
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
